TESSERA THERAPEUTICS
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large therapeutic messages into the genome, thereby curing diseases at their source. Gene Writing holds the potential to become a new category in genetic medicine, building upon recent breakthroughs in gene therapy and gene editing while eliminating important limitations in their reach, utilization, and efficacy. Tessera Therapeutics was founded by Flagship Pioneering, a life sciences innovation enterprise that conceives, resources, and develops first-in-category companies to transform human health and sustainability.
TESSERA THERAPEUTICS
Industry:
Biopharma Biotechnology Genetics Life Science Therapeutics
Founded:
2018-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.tesseratherapeutics.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
531.76 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Nginx
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Sio Gene Therapies
Sio Gene Therapies is a clinical-stage biopharmaceutical company.
Ensoma
Ensomaa is a genomic medicine company.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Lacerta Therapeutics
Lacerta Therapeutics is a clinical stage gene therapy company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
MicroSintesis
MicroSintesis is a life science company
OnDosis
OnDosis is a Swedish life science start-up.
Repertoire Immune Medicines
Repertoire Immune Medicines is a clinical stage biotechnology company.
Caraway Therapeutics
Rheostat Therapeutics is a bio therapeutics company.
Stemson Therapeutics
Stemson Therapeutics is a pre-clinical stage cell therapy company.
Werewolf Therapeutics
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Zelira Therapeutics
Zelira Therapeutics is a leading global therapeutic medicinal cannabis company.
Current Employees Featured
Founder
Investors List
Longevity Vision Fund
Longevity Vision Fund investment in Series C - Tessera Therapeutics
CDH Investments
CDH Investments investment in Series C - Tessera Therapeutics
SALT Fund
SALT Fund investment in Series C - Tessera Therapeutics
Hanwha Impact Partners
Hanwha Impact Partners investment in Series C - Tessera Therapeutics
March Capital
March Capital investment in Series C - Tessera Therapeutics
Alaska Permanent Fund
Alaska Permanent Fund investment in Series C - Tessera Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Tessera Therapeutics
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series C - Tessera Therapeutics
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Tessera Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series C - Tessera Therapeutics
Official Site Inspections
http://www.tesseratherapeutics.com Semrush global rank: 1.8 M Semrush visits lastest month: 12.73 K
- Host name: 413450.cloudwaysapps.com
- IP address: 167.172.146.87
- Location: North Bergen United States
- Latitude: 40.793
- Longitude: -74.0247
- Metro Code: 501
- Timezone: America/New_York
- Postal: 07047
More informations about "Tessera Therapeutics" on Search Engine
Tessera Therapeutics | Leadership
Contact. Leadership. Cures are in our DNA. Our team has deep genetic medicine expertise. Senior Leadership. Michael Severino. Chief Executive Officer, Board Director. Howard …See details»
Tessera Therapeutics - Crunchbase Company Profile
Details. Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write …See details»
Tessera Therapeutics | Biology
Our stepwise approach. We are harnessing MGEs to create the most effective Gene Writing™ technology using a combination of computational tools and wet-lab …See details»
Tessera Therapeutics | Delivery
We are advancing our proprietary technology to direct LNPs to go not only to the liver but beyond. Targeted delivery of our Gene Writers to tissues beyond the liver is essential to …See details»
Tessera Therapeutics Adds New Executives to its
Dec 8, 2021 CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Tessera Therapeutics, a biotechnology company pioneering a new approach in genetic medicine known as Gene …See details»
Tessera Therapeutics | LinkedIn
Tessera Therapeutics | LinkedIn. Biotechnology Research. Somerville, MA 31,293 followers. We are pioneering Gene Writing (TM) beyond its current limitations. View all 365 employees. About us....See details»
Leading Gene Writing Company Tessera Therapeutics …
Jul 14, 2021 CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Tessera Therapeutics, a biotechnology company pioneering a new approach in genetic medicine known as Gene …See details»
Tessera Therapeutics Announces Over $300M Series C …
Apr 19, 2022 Tessera Therapeutics was founded by Flagship Pioneering in 2018, a life sciences innovation enterprise that conceives, resources, and develops first-in-category …See details»
Tessera Therapeutics Expands Leadership and Board
Aug 24, 2022 CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Tessera Therapeutics, the biotechnology company pioneering GENE WRITING™ technology, today announced the …See details»
Tessera Therapeutics Presents New Preclinical Data
SOMERVILLE, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- Tessera Therapeutics, a biotechnology company pioneering a new approach to genome engineering through the …See details»
Tessera Therapeutics stacks up more than $300M in series C …
Apr 19, 2022 Tessera Therapeutics, founded and created by life sciences VC staple Flagship Pioneering, is building a war chest with a fresh $300 million for its trio of gene …See details»
Tessera Therapeutics Presents New Preclinical Data Highlighting ...
SOMERVILLE, Mass., May 10, 2024 (GLOBE NEWSWIRE) -- Tessera Therapeutics, a biotechnology company pioneering a new approach to genome engineering through the …See details»
Tessera Therapeutics | Focus Areas
At Tessera, we are advancing our Gene Writing™ technology and proprietary LNP delivery system to alter the human genome and effect precise, durable therapeutic change to …See details»
Tessera Therapeutics Highlights Advancements Across its
SOMERVILLE, Mass., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene …See details»
Tessera Therapeutics Presents New Data Demonstrating the …
Fri, May 19, 2023, 6:00 AM 6 min read. Tessera Therapeutics. RNA Gene Writing™ platform demonstrates continued advances in rewriting to correct pathogenic mutations responsible for...See details»
Tessera Therapeutics | News
Tessera Therapeutics Presents New Preclinical Data Highlighting Advancements Across Its Portfolio Programs and Platforms at the American Society of Gene and Cell Therapy …See details»
Tessera Therapeutics to Present New Data Across Preclinical …
SOMERVILLE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Tessera Therapeutics, a biotechnology company pioneering a new approach to genome engineering through the …See details»
Tessera Therapeutics - Funding, Financials, Valuation & Investors
Highlights. Funding Rounds 3. Total Funding Amount. Unlock for free. Lead Investors 2. Investors 13. Funding. Tessera Therapeutics has raised a total of. $531.8M. in funding …See details»
Tessera Therapeutics Announces Over $300M… | Flagship …
Somerville, Mass., April 19, 2022 – Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as GENE WRITING technology, …See details»
Tessera Therapeutics - Contacts, Employees, Board Members, …
Tessera Therapeutics. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 6. Contacts 192. About. …See details»